best performing mid and large cap oct 2019 to jan 2020

Immunitybio (IBRX) had the highest return between October 1, 2019 and January 31, 2020 by a US stock with a market cap of $2B+, returning 413.8%.

ASSET DATE % RETURN
Immunitybio (IBRX)
10/1/2019 - 1/31/2020
413.82%
Axsome Therapeutics (AXSM)
10/1/2019 - 1/31/2020
328.74%
Intracellular Th (ITCI)
10/1/2019 - 1/31/2020
204.56%
Tesla (TSLA)
10/1/2019 - 1/31/2020
169.39%
TG Therapeutics (TGTX)
10/1/2019 - 1/31/2020
151.95%
Nio Inc Class A ADR (NIO)
10/1/2019 - 1/31/2020
150.33%
Bloom Energy (BE)
10/1/2019 - 1/31/2020
141.72%
Soleno Therapeutics (SLNO)
10/1/2019 - 1/31/2020
130.67%
Surgery Partners (SGRY)
10/1/2019 - 1/31/2020
128.59%
Sitime (SITM)
10/1/2019 - 1/31/2020
95.54%
Sibanye Gold Ltd ADR (SBSW)
10/1/2019 - 1/31/2020
86.13%
BioNTech SE (BNTX)
10/1/2019 - 1/31/2020
77.03%
Apellis Pharmaceuticals (APLS)
10/1/2019 - 1/31/2020
71.43%
Hecla Mining (HL)
10/1/2019 - 1/31/2020
70.43%
Dynatrace Holdings LLC (DT)
10/1/2019 - 1/31/2020
69.24%
Vicor (VICR)
10/1/2019 - 1/31/2020
68.29%
Synaptics (SYNA)
10/1/2019 - 1/31/2020
66.68%
Ringcentral (RNG)
10/1/2019 - 1/31/2020
63.82%
Xenon Pharmaceuticals (XENE)
10/1/2019 - 1/31/2020
63.21%
Advanced Micro Devices (AMD)
10/1/2019 - 1/31/2020
61.79%
DexCom (DXCM)
10/1/2019 - 1/31/2020
60.92%
BridgeBio Pharma (BBIO)
10/1/2019 - 1/31/2020
60.57%
Equinox Gold (EQX)
10/1/2019 - 1/31/2020
60.19%
Penn National Gaming (PENN)
10/1/2019 - 1/31/2020
59.6%
Zai Lab (ZLAB)
10/1/2019 - 1/31/2020
58.8%